CREB5 and head and neck squamous cell carcinoma: To determine whether double-targeting of CREB5 and TOP1MT overcomes HNSCC resistance to cisplatin, we established a cisplatin-resistant xenograft model of HNSCC by subcutaneously injecting HN30/DDP cells into the buttocks of nude mice.